Related Experiment Video
Updated: Jun 23, 2026

Parallel Measurement of Circadian Clock Gene Expression and Hormone Secretion in Human Primary Cell Cultures
Published on: November 11, 2016
Plasminogen activator inhibitor-1 and the circadian clock in metabolic disorders
1Clock Cell Biology Research Group, Institute for Biological Resources and Functions, National Institute of Advanced Industrial Science and Technology, Central 6, 1-1-1 Higashi, Tsukuba, Ibaraki, Japan. k-ooishi@aist.go.jp
Insights
Circadian clock proteins regulate plasminogen activator inhibitor-1 (PAI-1) gene expression, impacting morning hypofibrinolysis. This circadian rhythm is vital for metabolic health, particularly in obesity and diabetes.
Area of Science:
- Chronobiology
- Molecular Biology
- Physiology
Background:
- Plasma levels of plasminogen activator inhibitor-1 (PAI-1) exhibit significant circadian fluctuations, leading to hypofibrinolysis in the early morning.
- The circadian expression of the PAI-1 gene is primarily controlled by core circadian clock proteins, including CLOCK and BMAL1/BMAL2.
Purpose of the Study:
- To investigate the role of circadian clock proteins in regulating PAI-1 expression and its impact on fibrinolysis.
- To explore the connection between circadian clock proteins, PAI-1, and metabolic disorders like obesity and diabetes.
Main Methods:
- Analysis of plasma PAI-1 levels in diurnal and nocturnal species to establish circadian patterns.
- Investigating the regulatory mechanisms of PAI-1 gene expression by circadian clock proteins.
Main Results:
- Plasma PAI-1 levels show a consistent increase at the onset of the active phase in both humans and rodents.
- Circadian clock proteins are crucial for the hypofibrinolytic state associated with metabolic disorders such as obesity and diabetes.
Conclusions:
- Rhythmic PAI-1 expression, driven by circadian clock proteins, is essential for physiological processes across species.
- Circadian clock proteins play a significant role in the hypofibrinolysis observed in metabolic diseases, highlighting potential therapeutic targets.
Abstract:
Plasma PAI-1 levels robustly fluctuate in a circadian manner and consequently contribute to hypofibrinolysis during the early morning. The circadian expression of PAI-1 gene is thought to be directly regulated by the circadian clock proteins such as CLOCK and BMAL1/BMAL2 which drive the endogenous biological clock. Plasma PAI-1 levels are increased in the beginning of the active phase in both diurnal humans and in nocturnal rodents, suggesting that the rhythmic PAI-1 expression is commonly indispensable for organisms. A series of our recent studies revealed that circadian clock proteins are important for hypofibrinolysis induced by metabolic disorders such as obesity and diabetes.
Related Concept Videos
Circadian Rhythms and Gene Regulation
Circadian Rhythms and Gene Regulation
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Biological Clocks and Seasonal Responses
Cytoskeletal Linker Proteins - Plakins
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...

